Literature DB >> 2582780

Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.

I C Macdougall1, I Cavill, M E Davies, R D Hutton, G A Coles, J D Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2582780     DOI： 10.1159/000417898

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  4 in total

1.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1990-03-10

Review 2.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 3.  Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

Authors:  I C Macdougall; D E Roberts; G A Coles; J D Williams
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

4.  Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.

Authors:  J E Howarth; H M Waters; D Shanks; K Hyde; J A Yin; C G Geary; E Anastassiades; D Howarth; R Gokal
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.